Itolizumab, the monoclonal antibody designed in Cuba, is making its way into the world
The drug has proven effective in patients with psoriasis, COVID-19 and lupus nephritis, inside and outside Cuba.
Tag: Itolizumab
Most Read
Most Commented
-
Itolizumab, the monoclonal antibody designed in Cuba, is making its way into the world
-
What foods can be brought to Cuba and what imports are forbidden?
-
Jusvinza, the Cuban hope against rheumatoid arthritis
-
Melagenina Plus, Cuba’s hope against vitiligo, being tested
-
Two hurricanes, an earthquake and Trump
